{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:18:48Z","timestamp":1768346328167,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,27]]},"DOI":"10.7759\/cureus.49535","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T07:37:14Z","timestamp":1701157034000},"source":"Crossref","is-referenced-by-count":1,"title":["A Comparison of the Minimum Inhibitory Concentration of Antibiotics in Staphylococcus Species Isolated From Orthopedic and Respiratory Medicine Infections"],"prefix":"10.7759","author":[{"given":"Akito","family":"Tomoyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyonmin","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Yukizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Higashihira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Takagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5312\/wjo.v5.i3.218","article-title":"Can periprosthetic hip joint infections be successfully managed by debridement and prosthesis retention?","volume":"5","author":"Anagnostakos K","year":"2014","unstructured":"Anagnostakos K, Schmitt C. Can periprosthetic hip joint infections be successfully managed by debridement and prosthesis retention?. World J Orthop. 2014, 5:218-24. 10.5312\/wjo.v5.i3.218","journal-title":"World J Orthop"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-011-2030-8","article-title":"Two-stage exchange arthroplasty for infected total knee arthroplasty: predictors of failure","volume":"469","author":"Mortazavi SM","year":"2011","unstructured":"Mortazavi SM, Vegari D, Ho A, Zmistowski B, Parvizi J. Two-stage exchange arthroplasty for infected total knee arthroplasty: predictors of failure. Clin Orthop Relat Res. 2011, 469:3049-54. 10.1007\/s11999-011-2030-8","journal-title":"Clin Orthop Relat Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2023.02.025","article-title":"Increased incidence of methicillin-resistant Staphylococcus aureus in knee and hip prosthetic joint infection","volume":"38","author":"Hays MR","year":"2023","unstructured":"Hays MR, Kildow BJ, Hartman CW, Lyden ER, Springer BD, Fehring TK, Garvin KL. Increased incidence of methicillin-resistant Staphylococcus aureus in knee and hip prosthetic joint infection. J Arthroplasty. 2023, 38:S326-30. 10.1016\/j.arth.2023.02.025","journal-title":"J Arthroplasty"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets","volume":"52","author":"Kullar R","year":"2011","unstructured":"Kullar R, Davis SL, Levine DP, Rybak MJ. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Clin Infect Dis. 2011, 52:975-81. 10.1093\/cid\/cir124","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05","volume":"60","author":"Steinkraus G","year":"2007","unstructured":"Steinkraus G, White R, Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemother. 2007, 60:788-94. 10.1093\/jac\/dkm258","journal-title":"J Antimicrob Chemother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2008.04.003","article-title":"Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections","volume":"57","author":"Dombrowski JC","year":"2008","unstructured":"Dombrowski JC, Winston LG. Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections. J Infect. 2008, 57:110-5. 10.1016\/j.jinf.2008.04.003","journal-title":"J Infect"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat LK","year":"2006","unstructured":"Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med. 2006, 166:2138-44. 10.1001\/archinte.166.19.2138","journal-title":"Arch Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas G","year":"2004","unstructured":"Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2004, 42:2398-402. 10.1128\/JCM.42.6.2398-2402.2004","journal-title":"J Clin Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis","volume":"54","author":"van Hal SJ","year":"2012","unstructured":"van Hal SJ, Lodise TP, Paterson DL. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis. 2012, 54:755-71. 10.1093\/cid\/cir935","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-009-0837-y","article-title":"Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection","volume":"29","author":"Ferry T","year":"2010","unstructured":"Ferry T, U\u00e7kay I, Vaudaux P, et al.. Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection. Eur J Clin Microbiol Infect Dis. 2010, 29:171-80. 10.1007\/s10096-009-0837-y","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2013.02.018","article-title":"In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections","volume":"41","author":"Molina-Manso D","year":"2013","unstructured":"Molina-Manso D, del Prado G, Ortiz-P\u00e9rez A, Manrubia-Cobo M, G\u00f3mez-Barrena E, Cordero-Ampuero J, Esteban J. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections. Int J Antimicrob Agents. 2013, 41:521-3. 10.1016\/j.ijantimicag.2013.02.018","journal-title":"Int J Antimicrob Agents"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03132-14","article-title":"Extracellular DNA impedes the transport of vancomycin in Staphylococcus epidermidis biofilms preexposed to subinhibitory concentrations of vancomycin","volume":"58","author":"Doroshenko N","year":"2014","unstructured":"Doroshenko N, Tseng BS, Howlin RP, et al.. Extracellular DNA impedes the transport of vancomycin in Staphylococcus epidermidis biofilms preexposed to subinhibitory concentrations of vancomycin. Antimicrob Agents Chemother. 2014, 58:7273-82. 10.1128\/AAC.03132-14","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt086","article-title":"Antibiotic pressure can induce the viable but non-culturable state in Staphylococcus aureus growing in biofilms","volume":"68","author":"Pasquaroli S","year":"2013","unstructured":"Pasquaroli S, Zandri G, Vignaroli C, Vuotto C, Donelli G, Biavasco F. Antibiotic pressure can induce the viable but non-culturable state in Staphylococcus aureus growing in biofilms. J Antimicrob Chemother. 2013, 68:1812-7. 10.1093\/jac\/dkt086","journal-title":"J Antimicrob Chemother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00590-016-1879-3","article-title":"Clinical and epidemiological differences between implant-associated and implant-free orthopaedic infections","volume":"27","author":"Cu\u00e9rel C","year":"2017","unstructured":"Cu\u00e9rel C, Abrassart S, Billi\u00e8res J, Andrey D, Suva D, Dubois-Ferri\u00e8re V, U\u00e7kay I. Clinical and epidemiological differences between implant-associated and implant-free orthopaedic infections. Eur J Orthop Surg Traumatol. 2017, 27:229-31. 10.1007\/s00590-016-1879-3","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125818","article-title":"Epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration","volume":"10","author":"Garc\u00eda de la M\u00e0ria C","year":"2015","unstructured":"Garc\u00eda de la M\u00e0ria C, Cervera C, Peric\u00e0s JM, et al.. Epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentration. PLoS One. 2015, 10:e0125818. 10.1371\/journal.pone.0125818","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01769-09","article-title":"Laboratory and clinical characteristics of Staphylococcus lugdunensis prosthetic joint infections","volume":"48","author":"Shah NB","year":"2010","unstructured":"Shah NB, Osmon DR, Fadel H, et al.. Laboratory and clinical characteristics of Staphylococcus lugdunensis prosthetic joint infections. J Clin Microbiol. 2010, 48:1600-3. 10.1128\/JCM.01769-09","journal-title":"J Clin Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2012.00938.x","article-title":"Pathogenesis and treatment concepts of orthopaedic biofilm infections","volume":"65","author":"Zimmerli W","year":"2012","unstructured":"Zimmerli W, Moser C. Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol. 2012, 65:158-68. 10.1111\/j.1574-695X.2012.00938.x","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-012-0325-7","article-title":"Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study","volume":"41","author":"Achermann Y","year":"2013","unstructured":"Achermann Y, Eigenmann K, Ledergerber B, et al.. Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study. Infection. 2013, 41:431-7. 10.1007\/s15010-012-0325-7","journal-title":"Infection"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2022.03.072","article-title":"The use of rifampin in total joint arthroplasty: a systematic review and meta-analysis of comparative studies","volume":"37","author":"Kruse CC","year":"2022","unstructured":"Kruse CC, Ekhtiari S, Oral I, et al.. The use of rifampin in total joint arthroplasty: a systematic review and meta-analysis of comparative studies. J Arthroplasty. 2022, 37:1650-7. 10.1016\/j.arth.2022.03.072","journal-title":"J Arthroplasty"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2429-2","article-title":"Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study","volume":"17","author":"Leijtens B","year":"2017","unstructured":"Leijtens B, Elbers JB, Sturm PD, Kullberg BJ, Schreurs BW. Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study. BMC Infect Dis. 2017, 17:321. 10.1186\/s12879-017-2429-2","journal-title":"BMC Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.56.7715","article-title":"Clinical characteristics of methicillin-resistant coagulase-negative staphylococcal bacteremia in a tertiary hospital","volume":"56","author":"Yamada K","year":"2017","unstructured":"Yamada K, Namikawa H, Fujimoto H, et al.. Clinical characteristics of methicillin-resistant coagulase-negative staphylococcal bacteremia in a tertiary hospital. Intern Med. 2017, 56:781-5. 10.2169\/internalmedicine.56.7715","journal-title":"Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.16.01002","article-title":"Oral-only linezolid-rifampin is highly effective compared with other antibiotics for periprosthetic joint infection: study of a mouse model","volume":"99","author":"Thompson JM","year":"2017","unstructured":"Thompson JM, Saini V, Ashbaugh AG, et al.. Oral-only linezolid-rifampin is highly effective compared with other antibiotics for periprosthetic joint infection: study of a mouse model. J Bone Joint Surg Am. 2017, 99:656-65. 10.2106\/JBJS.16.01002","journal-title":"J Bone Joint Surg Am"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/207650-a-comparison-of-the-minimum-inhibitory-concentration-of-antibiotics-in-staphylococcus-species-isolated-from-orthopedic-and-respiratory-medicine-infections","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:06:32Z","timestamp":1707509192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/207650-a-comparison-of-the-minimum-inhibitory-concentration-of-antibiotics-in-staphylococcus-species-isolated-from-orthopedic-and-respiratory-medicine-infections"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.49535","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,27]]}}}